Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia

Biomedicine and Pharmacotherapy

Volumn 60, Issue 4, 2006, Pages 182-185

  Revilla Monsalve, Cristina ^a   Zendejas Ruiz, Iván ^b   Islas Andrade, Sergio ^a   Báez Saldaña, Armida ^c   Palomino Garibay, Miguel Angel ^a   Hernández Quiróz, Pedro Martín ^c   Fernandez Mejia, Cristina ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Biomedical Research Institute   (Mexico)

^c National University of   (Mexico)

Author keywords

Biotin; Triacylglycerol; Type 2 diabetes

Indexed keywords

BIOTIN; CHOLESTEROL; GLUCOSE; INSULIN; LIPID; PLACEBO; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AGED; BIOTIN; CHOLESTEROL, VLDL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 33744999394     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.03.005     Document Type: Article

References (33)

1. Carlberg C. Lipid soluble vitamins in gene regulation. Biofactors 10 (1999) 91-97
2. Biotin. In: Combs Jr. G.F. (Ed). The Vitamins. Fundamental Aspects in Nutrition and Health. 2nd Edition (1994), Academic Press Inc, San Diego 329-345
3. Hinds T.S., West W.L., and Knight E.M. Carotenoids and retinoids: a review of research, clinical, and public health applications. J. Clin. Pharmacol. 37 (1997) 551-558
4. Wu-Wong J.R., Tian J., and Goltzman D. Vitamin D analogs as therapeutic agents: a clinical study update. Curr. Opin. Investig. Drugs 5 (2004) 320-326
5. Brandsch R. Regulation of gene expression by cofactors derived from B vitamins. J. Nutr. Sci. Vitaminol. (Tokyo) 40 (1994) 371-399
6. Tully D.B., Allgood V.E., and Cidlowski J.A. Modulation of steroid receptor-mediated gene expression by vitamin B6. FASEB J. 8 (1994) 343-349
7. Rodriguez-Melendez R., and Zempleni J. Regulation of gene expression by biotin. J. Nutr. Biochem. 14 (2003) 680-690
8. Zempleni J. Uptake, localization, and noncarboxylase roles of biotin. Annu. Rev. Nutr. 25 (2005) 175-196
9. Watanabe T. Morphological and biochemical effects of excessive amounts of biotin on embryonic development in mice. Experientia 52 (1996) 149-154
10. Báez-Saldaña A., Díaz G., Espinoza B., and Ortega E. Biotin deficiency induces changes in subpopulations of spleen lymphocytes in mice. Am. J. Clin. Nutr. 64 (1998) 431-437
11. Dakshinamurti K. Biotin: a regulator of gene expression. J. Nutr. Biochem. 16 (2005) 419-423
12. Fernandez-Mejia C. Pharmacological effects of biotin. J. Nutr. Biochem. 16 (2005) 424-427
13. Chauhan J., and Dakshimamurti K. Transcriptional regulation of the glucokinase gene by biotin in starved rats. J. Biol. Chem. 266 (1991) 10035-10038
14. Borboni P., Magnaterra R., Rabini R.A., Staffolanni R., Porzio O., Sesti G., et al. Effect of biotin on glucokinase activity, mRNA expression and insulin release in cultured beta-cells. Acta Diabetol. 33 (1996) 154-158
15. Romero-Navarro G., Cabrera-Valladares G., German M.S., Matschinsky F.M., Wang J., and Fernandez-Mejia C. Biotin regulation of pancreatic glucokinase and insulin in primary cultured rat islets and in biotin deficient rats. Endocrinology 140 (1999) 4500-4595
16. Yoshikawa H., Tajiri Y., Sako Y., Hashimoto T., Umeda F., and Nawata H. Effects of biotin on glucotoxycity of lipotoxicity in rat pancreatic islets. Metabolism 51 (2002) 163-168
17. Dakshinamurti K., and Li W. Transcriptional regulation of the liver phosphoenolpyruvate carboxykinase by biotin in diabetic rats. Mol. Cell. Biochem. 132 (1994) 127-132
18. Coggeshall J.C., Heggers J.P., Robson M.C., and Baker H. Biotin status and plasma glucose levels in diabetics. Ann. N. Y. Acad. Sci. 447 (1985) 389-392
19. Maebashi M., Makino Y., Furukawa Y., Ohinata K., Kimura S., and Takao S. Therapeutic evaluation of the effect of biotin on hyperglycemia in patients with Non-Insulin Diabetes Mellitus. J Clin Biochem Nutr 14 (1993) 211-218
20. Reddi A., DeAngelis B., Frank O., Lasker N., and Baker H. Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK mice. Life Sci. 42 (1988) 1323-1330
21. Zhang H., Osada K., Maebeshi M., Ito M., Komai M., and Furukawa Y. A high biotin diet improves the impaired glucose tolerance of long term spontaneosly hyperglycemic rats with non-insulin dependent mellitus. J. Nutr. Sci. Vitaminol. (Tokyo) 42 (1997) 517-526
22. Koustikos D., Fourtounas C., Kapetanaki A., Agroyannis B., Tzanatos H., Rammos G., et al. Oral glucose test after high-dose i.v. biotin administration in normoglucemic hemodialysis patients. Ren. Fail. 18 (1966) 131-137
23. Marshall M.W., Smith B.P., and Lehman R.P. Dietary response of two genetically different lines of inbred rats: Lipids in serum and liver. Proc. Soc. Exp. Biol. Med. 131 (1969) 1271-1277
24. Marshall M.W., Haubrich M., Washington V.A., Chang M.W., Young C.W., and Wheeler M.A. Biotin status and lipid metabolism in adult obese hypercholesterolemic inbread rats. Nutr. Metab. 20 (1976) 41-61
25. Marshall M.W., Kliman P.G., and Washington V.A. Effects of biotin on lipids and on other constituents of plasma of healthy men and women. Artery 7 (1980) 330-351
26. Dukusova O.D., and Krivoruchenko I.V. The effect of biotin on the blood cholesterol levels of atherosclerotic patients in idiopathic hyperlipidemia. Kardiologiia 12 (1972) 113
27. Scott D. Clinical biotin deficiency report of a case with some remarks on serum cholesterol. Acta Med. Scand. 162 (1958) 69-70
28. Báez-Saldaña A., Zendejas-Ruiz I., Revilla-Monsalve C., Islas-Andrade S., Cárdenas A., Rojas-Ochoa A., et al. Effects of biotin on pyruvate carboxylase, acetyl-CoA carboxylase, propionyl CoA carboxylase, and markers for glucose and lipid homeostasis in type 2 diabetic patients and in nondiabetic subjects. Am. J. Clin. Nutr. 79 (2004) 238-243
29. Lewis B., Rathman S., and McMahon R. Dietary biotin intake modulates the pool of free and protein-bound biotin in rat liver. J. Nutr. 131 (2001) 2310-2315
30. Munday M.R., and Hemingway C.J. The regulation of acetyl-CoA carboxylase-a potential target for the action of hypolipidemic agents. Adv. Enzyme Regul. 39 (1999) 205-234
31. Ito M.K. Niacin-based therapy for dyslipidemia: past evidence and future advances. Am. J. Manag. Care 8 (2002) S315-S322
32. Mukherjee R., Davies P., Crombie D.L., Bischoff E.D., Cesario R.M., Jow L., et al. Sensitization of diabetic and obese mice to insulin by retinoic X receptor agonist. Nature 386 (1997) 407-410
33. Liu Y.L., Sennitt M.V., Hislop D.C., Crombie D.L., Heyman R.A., and Cawthorne M.A. Rexinoid X receptor have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats. Int. J. Obes. Relat. Metab. Disord. 24 (2000) 997-1004